January 14, 2026
Alzheimer’s PREVENTION Mid-Trial Results Published
Lifestyle and Medical Management Boosts Brain Blood Flow and Reduces Diabetes Risk in Early Alzheimer’s Disease, PREVENTION Mid-Trial Findings Reveal.
September 19, 2025
The PENS Trial: Breakthrough Evidence for Treating Idiopathic Normal Pressure Hydrocephalus (iNPH)
Idiopathic normal pressure hydrocephalus (iNPH) is a treatable neurological condition caused by a buildup of cerebrospinal fluid in the brai…
September 3, 2025
PNI Physicians Gain Endowed Chairs for Innovation, Research, Education and Advancing Patient Care
We are honored to celebrate two Pacific Neuroscience Institute physicians recognized with endowed chair appointments at Saint John’s Healt…
May 30, 2025
Can Lifestyle Changes Impact Alzheimer’s Disease? Early Findings from Brain Blood Flow Study
Early results from the PREVENTION Trial suggest lifestyle changes may boost brain blood flow in Alzheimer’s disease patients. Learn what this means for you.
September 14, 2023
AD-NeuroScore: Our Innovative Approach to Alzheimer’s Detection
Introducing AD-NeuroScore, an innovative approach to early Alzheimer’s disease detection and tracking. Developed by Jennifer Bramen, PhD, at Pacific Neuroscience Institute Foundation, this novel solution uses advanced MRI technology and a unique algorithm to simplify and improve Alzheimer’s-specific neurodegeneration assessment.
August 29, 2023
Study finds abdominal body fat linked to brain shrinkage, possible dementia
An international study reveals a link between abdominal body fat and brain atrophy, potentially leading to dementia. Explore the groundbreaking findings from Pacific Neuroscience Institute's Brain Health Center, shedding light on how abdominal fat affects brain health and Alzheimer's risk. Learn how this research can influence early intervention and healthier lifestyles to mitigate dementia risks.
December 19, 2022
PNI Study Links Muscular Strength and Mobility to Brain Health
Results from a clinical research study co-authored by physicians and scientists at the Pacific Neuroscience Institute ® (PNI) at Providence Saint John’s Health Center indicate a correlation between two modifiable risk factors – muscular strength and mobility – and brain atrophy among persons with Alzheimer’s disease.
November 10, 2022
Breaking Barriers for Brain Tumor Research
Board-certified and fellowship-trained neurosurgeon Garni Barhoudarian, MD, opened the American Brain Tumor Association's BT5K walk and run event in Los Angeles on November 5th, 2022. The annual event promotes brain tumor awareness and support for patients and their families.
August 4, 2022
Largest Study of Brain Tumor “Keyhole” Surgery for Meningiomas
PNI surgeons demonstrate outstanding outcomes with minimally invasive keyhole surgery for meningioma brain tumors, in groundbreaking 13-year study.
December 1, 2021
The Role of Clinical Trials at PNI
Clinical trials are research studies that play a critical role in the advancement of clinical and medical knowledge about disease. At Pacific Neuroscience Institute (PNI), there are a number of upcoming and ongoing trials for patients with various neurological conditions.